Prognostic indicators in primary biliary cirrhosis: significance of revised IAHG (International Autoimmune Hepatitis Group) score
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Primary biliary cirrhosis (PBC) is a slowly progressing autoimmune disease of the liver that is characterized by portal inflammation and immune-mediated destruction of the intrahepatic bile ducts. Serum total bilirubin is one of the various prognostic factors that have been proposed. A recent study found that PBC with accompanying autoimmune hepatitis (AIH) carries a negative prognosis. This study examined the clinical characteristics of PBC and analyzed the factors that affect its prognosis. Methods: Patients diagnosed with PBC between January 1998 and December 2010 based on clinical and histopathological findings were compiled and analyzed retrospectively. Results: Among 27 patients, 24 (1 male and 23 females, ages 50.0±9.3 years) were followed up. The follow-up period was 8.6±0.9 years. Of the 24 patients, 9 patients progressed to liver cirrhosis (LC). Comparison between patients who did and did not progress to LC revealed statistically significant differences in the patients’ serum total bilirubin (2.7±1.8vs. 0.8±0.4, P =0.012), the Mayo risk score (5.1±0.7 vs. 3.9±0.6, P =0.001), the revised IAHG (International Autoimmune Hepatitis Group) score (9.2±2.3 vs. 5.4±3.0, P=0.004) and frequency of AIH overlap (5/9 [55.6%] vs. 0/15 [0%], P=0.001) at the time of diagnosis. Conclusions: We propose that serum total bilirubin, the Mayo risk score, and the revised IAHG score at the time of diagnosis are helpful for predicting PBC prognosis. In particular, since all of the patients with accompanying AIH progressed to LC, the presence of overlap syndrome at the time of diagnosis is helpful for predicting PBC prognosis and providing an adequate treatment. (Clin Mol Hepatol 2012;18:375-382)
Abstract
Background/Aims: Primary biliary cirrhosis (PBC) is a slowly progressing autoimmune disease of the liver that is characterized by portal inflammation and immune-mediated destruction of the intrahepatic bile ducts. Serum total bilirubin is one of the various prognostic factors that have been proposed. A recent study found that PBC with accompanying autoimmune hepatitis (AIH) carries a negative prognosis. This study examined the clinical characteristics of PBC and analyzed the factors that affect its prognosis. Methods: Patients diagnosed with PBC between January 1998 and December 2010 based on clinical and histopathological findings were compiled and analyzed retrospectively. Results: Among 27 patients, 24 (1 male and 23 females, ages 50.0±9.3 years) were followed up. The follow-up period was 8.6±0.9 years. Of the 24 patients, 9 patients progressed to liver cirrhosis (LC). Comparison between patients who did and did not progress to LC revealed statistically significant differences in the patients’ serum total bilirubin (2.7±1.8vs. 0.8±0.4, P =0.012), the Mayo risk score (5.1±0.7 vs. 3.9±0.6, P =0.001), the revised IAHG (International Autoimmune Hepatitis Group) score (9.2±2.3 vs. 5.4±3.0, P=0.004) and frequency of AIH overlap (5/9 [55.6%] vs. 0/15 [0%], P=0.001) at the time of diagnosis. Conclusions: We propose that serum total bilirubin, the Mayo risk score, and the revised IAHG score at the time of diagnosis are helpful for predicting PBC prognosis. In particular, since all of the patients with accompanying AIH progressed to LC, the presence of overlap syndrome at the time of diagnosis is helpful for predicting PBC prognosis and providing an adequate treatment. (Clin Mol Hepatol 2012;18:375-382)
참고문헌 (36)
- Kaplan MM, "Primary biliary cirrhosis", N Engl J Med, 353, pp.1261~1273 (2005)
- Talwalkar JA, "Primary biliary cirrhosis", Lancet, 362, pp.53~61 (2003)
- Bhandari BM, "Primary biliary cirrhosis", Gastroenterol Clin North Am, 40, pp.373~386 (2011)
- Jones DE, "Pathogenesis of primary biliary cirrhosis", Gut, 56, pp.1615~1624 (2007)
- Hirschfield GM, "Pathogenesis of cholestatic liver disease and therapeutic approaches", Gastroenterology, 139, pp.1481~1496 (2010)
- Sood S, "Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations", Gastroenterology, 127, pp.470~475 (2004)
- Metcalf J, "The geoepidemiology of primary biliary cirrhosis", Semin Liver Dis, 17, pp.13~22 (1997)
- 김경아, "한국인 원발성 담즙성 간경변증의 임상 특징 및 예후", Clinical and Molecular Hepatology, 16(2), pp.139~146 (2010), 대한간학회
- Inoue K, "Prediction of prognosis of primary biliary cirrhosis in Japan", Liver, 15, pp.70~77 (1995)
- Shapiro JM, "Serum bilirubin: a prognostic factor in primary biliary cirrhosis", Gut, 20, pp.137~140 (1979)
- Parés A, "Natural history of primary biliary cirrhosis", Clin Liver Dis, 7, pp.779~794 (2003)
- Silveira MG, "Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes", Am J Gastroenterol, 102, pp.1244~1250 (2007)
- Neuhauser M, "Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis", Am J Gastroenterol, 105, pp.345~353 (2010)
- Chazouillères O, "Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy", Hepatology, 28, pp.296~301 (1998)
- Talwalkar JA, "Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system", Am J Gastroenterol, 97, pp.1191~1197 (2002)
- Poupon R, "Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis", Hepatology, 44, pp.85~90 (2006)
- Johnson PJ, "Meeting report: International Autoimmune Hepatitis Group", Hepatology, 18, pp.998~1005 (1993)
- Alvarez F, "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis", J Hepatol, 31, pp.929~938 (1999)
- Ludwig J, "Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)", Virchows Arch A Pathol Anat Histol, 379, pp.103~112 (1978)
- Kim WR, "Epidemiology and natural history of primary biliary cirrhosis in a US community", Gastroenterology, 119, pp.1631~1636 (2000)
- van Hoogstraten HJ, "Prognostic factors and longterm effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group", J Hepatol, 31, pp.256~262 (1999)
- Angulo P, "Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid", Liver, 19, pp.115~121 (1999)
- Dickson ER, "Prognosis in primary biliary cirrhosis: model for decision making", Hepatology, 10, pp.1~7 (1989)
- Czaja AJ, "The variant forms of autoimmune hepatitis", Ann Intern Med, 125, pp.588~598 (1996)
- Poupon R, "Autoimmune overlapping syndromes", Clin Liver Dis, 7, pp.865~878 (2003)
- Czaja AJ, "Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries", J Hepatol, 44, pp.251~252 (2006)
- Papamichalis PA, "The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis", overlap syndromes and autoimmune hepatitis with concurrent other liver disorders, 2007, pp.4, 3~
- 이윤나, "한국인 자가면역성 간염을 진단하기 위한 Simplified Scoring Criteria의 가치 및 유용성", 대한내과학회지, 81(3), pp.340~350 (2011), 대한내과학회
- Poupon RE, "Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis", Gastroenterology, 113, pp.884~890 (1997)
- Cook GC, "Controlled prospective trial of corticosteroid therapy in active chronic hepatitis", Q J Med, 40, pp.159~185 (1971)
- Shi J, "Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials", Am J Gastroenterol, 101, pp.1529~1538 (2006)
- Poupon RE, "Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group", Hepatology, 29, pp.1668~1671 (1999)
- Hirschfield GM, "Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis", Nat Genet, 42, pp.655~657 (2010)
- Hirschfield GM, "Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes", Genes Immun, 13, pp.328~335 (2012)
- Hirschfield GM, "Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants", N Engl J Med, 360, pp.2544~2555 (2009)
- Mells GF, "Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis", Nat Genet, 43, pp.329~332 (2011)